Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lynn Van Ummersen"'
Autor:
Rebecca Marnocha, Yulin Zhang, Michael S. Huie, George Wilding, Amy Drezen, Dona Alberti, Jeffrey A. Douglas, Lynn Van Ummersen, Dottie Horvath, Kurt R. Oettel, Mary Jane Staab, Mann Kim Kyung
Publikováno v:
Investigational New Drugs. 24:255-260
Objective: To assess the efficacy and toxicity of the combination of interferon-alpha and doxycycline in patients with metastatic renal cell carcinoma and to assess the effect of this treatment on serum vascular endothelial growth factor (VEGF) level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d921158fa3e7d2f078b5c62a44054047
https://doi.org/10.1007/s10637-005-3903-z
https://doi.org/10.1007/s10637-005-3903-z
Autor:
Dona Alberti, Rebecca Marnocha, Kendra D. Tutsch, Lynn Van Ummersen, Rhoda Z. Arzoomanian, Jennifer Volkman, Kim Binger, Jill M. Kolesar, George Wilding
Publikováno v:
Clinical Cancer Research. 10:7450-7456
Perifosine (NSC 639966) is a synthetic, substituted heterocyclic alkylphosphocholine that acts primarily at the cell membrane targeting signal transduction pathways. Early clinical trials were limited because of dose-limiting gastrointestinal toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54fdaa9dacce9bca605495b5efb2f67
https://doi.org/10.1158/1078-0432.ccr-03-0406
https://doi.org/10.1158/1078-0432.ccr-03-0406
Autor:
Eric J. Small, Michael A. Carducci, James M. Burke, Ron Rodriguez, Lawrence Fong, Lynn van Ummersen, D.C. Yu, Junko Aimi, Dale Ando, Peter Working, David Kirn, George Wilding
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 14(1)
CG7870 is a replication-selective oncolytic adenovirus genetically engineered to replicate preferentially in prostate tissue. In a previous phase I/II clinical trial of intraprostatic delivery of CG7870 for locally recurrent prostate cancer this viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb251467b8a6ff6070ec74c709020641
https://pubmed.ncbi.nlm.nih.gov/16690359
https://pubmed.ncbi.nlm.nih.gov/16690359
Autor:
Emily Robinson, Lynn Van Ummersen, Kurt R. Oettel, George Wilding, Dorothea Horvath, David L. DeMets, Kendra D. Tutsch, Rhoda Z. Arzoomanian, James McGovern, Hamied Rezazadeh, Glenn Liu, Dona Alberti, Howard H. Bailey, Mary Jane Staab
Publikováno v:
Investigational new drugs. 21(3)
Objective. We conducted a phase II multicenter trial of perillyl alcohol in patients with advanced hormone refractory prostate cancer (HRPC). The primary endpoint was to evaluate the 6-month progression-free survival given the potential cytostatic na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a670c8d6efc19bdbdf3907e03cdb96cc
https://pubmed.ncbi.nlm.nih.gov/14578686
https://pubmed.ncbi.nlm.nih.gov/14578686
Autor:
Glenn, Liu, Jordan, Berlin, Kendra D, Tutsch, Lynn, Van Ummersen, Amy, Dresen, Rebecca, Marnocha, Rhoda, Arzomanian, Dona, Alberti, Chris, Feierabend, Kimberly, Binger, George, Wilding
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(3)
Penclomedine is a synthetic alpha-picoline derivative that has shown antitumor activity both in preclinical development and in Phase I work using an i.v. preparation. The main toxicities seen in those studies were dose dependent and mainly neurocereb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0fffb2d5f0e132c867af7a648342479
https://pubmed.ncbi.nlm.nih.gov/11895899
https://pubmed.ncbi.nlm.nih.gov/11895899
Autor:
Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Kim, Yulin Zhang, Mary Staab, Dottie Horvath, Rebecca Marnocha, Jeff Douglas, Amy Drezen, Dona Alberti, George Wilding
Publikováno v:
Investigational New Drugs; May2006, Vol. 24 Issue 3, p255-260, 6p
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 13:165-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a107a432b42b41f8437d7ef67c5e284
https://doi.org/10.1016/0360-3016(87)91161-8
https://doi.org/10.1016/0360-3016(87)91161-8